The global market for Computer-aided Detection (CAD) for Breast Cancer Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Computer-aided Detection (CAD) for Breast Cancer Screening include CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta and McKesson Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection (CAD) for Breast Cancer Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computer-aided Detection (CAD) for Breast Cancer Screening by region & country, by Type, and by Application.
The Computer-aided Detection (CAD) for Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection (CAD) for Breast Cancer Screening.
Market Segmentation
By Company
CureMetrix, Inc.
FUJIFILM Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
iCAD Inc.
IMS Giotto SpA
Konica Minolta
McKesson Corporation
Merge Healthcare (IBM Corporation)
Neusoft Corporation
Qlarity Imaging, LLC
Siemens Healthineers AG
Segment by Type:
Mammography CAD
MRI CAD
PET/CT CAD
Ultrasound CAD
Segment by Application
Clinics
Hospital
Medical Examination Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Computer-aided Detection (CAD) for Breast Cancer Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Computer-aided Detection (CAD) for Breast Cancer Screening Product Introduction
1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size Forecast
1.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Trends & Drivers
1.3.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industry Trends
1.3.2 Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers & Opportunity
1.3.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
1.3.4 Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Players Revenue Ranking (2023)
2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue by Company (2019-2024)
2.3 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Base Distribution and Headquarters
2.4 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Product Offered
2.5 Key Companies Time to Begin Mass Production of Computer-aided Detection (CAD) for Breast Cancer Screening
2.6 Computer-aided Detection (CAD) for Breast Cancer Screening Market Competitive Analysis
2.6.1 Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mammography CAD
3.1.2 MRI CAD
3.1.3 PET/CT CAD
3.1.4 Ultrasound CAD
3.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type
3.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (2019-2030)
3.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospital
4.1.3 Medical Examination Center
4.1.4 Others
4.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application
4.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (2019-2030)
4.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region
5.1.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024)
5.1.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030)
5.1.4 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.2.2 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.3.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.4.2 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.5.2 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.6.2 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value
6.3 United States
6.3.1 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.3.2 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.4.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.5.2 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.5.3 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.6.2 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.7.2 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.8.2 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.9.2 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.9.3 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CureMetrix, Inc.
7.1.1 CureMetrix, Inc. Profile
7.1.2 CureMetrix, Inc. Main Business
7.1.3 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.1.4 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.1.5 CureMetrix, Inc. Recent Developments
7.2 FUJIFILM Corporation
7.2.1 FUJIFILM Corporation Profile
7.2.2 FUJIFILM Corporation Main Business
7.2.3 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.2.4 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.2.5 FUJIFILM Corporation Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.3.4 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.3.5 Hitachi, Ltd. Recent Developments
7.4 Hitachi, Ltd.
7.4.1 Hitachi, Ltd. Profile
7.4.2 Hitachi, Ltd. Main Business
7.4.3 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.4.4 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.4.5 Hitachi, Ltd. Recent Developments
7.5 Hologic, Inc.
7.5.1 Hologic, Inc. Profile
7.5.2 Hologic, Inc. Main Business
7.5.3 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.5.4 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.5.5 Hologic, Inc. Recent Developments
7.6 iCAD Inc.
7.6.1 iCAD Inc. Profile
7.6.2 iCAD Inc. Main Business
7.6.3 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.6.4 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.6.5 iCAD Inc. Recent Developments
7.7 IMS Giotto SpA
7.7.1 IMS Giotto SpA Profile
7.7.2 IMS Giotto SpA Main Business
7.7.3 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.7.4 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.7.5 IMS Giotto SpA Recent Developments
7.8 Konica Minolta
7.8.1 Konica Minolta Profile
7.8.2 Konica Minolta Main Business
7.8.3 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.8.4 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.8.5 Konica Minolta Recent Developments
7.9 McKesson Corporation
7.9.1 McKesson Corporation Profile
7.9.2 McKesson Corporation Main Business
7.9.3 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.9.4 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.9.5 McKesson Corporation Recent Developments
7.10 Merge Healthcare (IBM Corporation)
7.10.1 Merge Healthcare (IBM Corporation) Profile
7.10.2 Merge Healthcare (IBM Corporation) Main Business
7.10.3 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.10.4 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.10.5 Merge Healthcare (IBM Corporation) Recent Developments
7.11 Neusoft Corporation
7.11.1 Neusoft Corporation Profile
7.11.2 Neusoft Corporation Main Business
7.11.3 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.11.4 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.11.5 Neusoft Corporation Recent Developments
7.12 Qlarity Imaging, LLC
7.12.1 Qlarity Imaging, LLC Profile
7.12.2 Qlarity Imaging, LLC Main Business
7.12.3 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.12.4 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.12.5 Qlarity Imaging, LLC Recent Developments
7.13 Siemens Healthineers AG
7.13.1 Siemens Healthineers AG Profile
7.13.2 Siemens Healthineers AG Main Business
7.13.3 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.13.4 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.13.5 Siemens Healthineers AG Recent Developments
8 Industry Chain Analysis
8.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industrial Chain
8.2 Computer-aided Detection (CAD) for Breast Cancer Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Computer-aided Detection (CAD) for Breast Cancer Screening Sales Model
8.5.2 Sales Channel
8.5.3 Computer-aided Detection (CAD) for Breast Cancer Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
CureMetrix, Inc.
FUJIFILM Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
iCAD Inc.
IMS Giotto SpA
Konica Minolta
McKesson Corporation
Merge Healthcare (IBM Corporation)
Neusoft Corporation
Qlarity Imaging, LLC
Siemens Healthineers AG
听
听
*If Applicable.
